Pre-order Enquiry
Request Free Sample
Healthcare
Aerospace & Defence
Agriculture
Automations
Chemicals & Advanced Materials
Food & Beverages
Information & Communication Technology
Oil & Gas
Power & Energy
TMVR, also known as transcatheter mitral valve replacement is a way of replacing the mitral valve in the heart without the need for conventional open-heart surgery. TMVR transcatheter mitral valve replacement is a treatment for mitral valve stenosis (tight mitral valve) or mitral valve regurgitation (leaky mitral valve) or a mix of the two. TMVR transcatheter mitral valve replacement was developed initially as a method of replacing the mitral valve in patients considered too high risk for surgery but will likely replace mitral valve replacement surgery in the future as the technology improves and the outcomes are proved.
Market Analysis and Insights: Global Transcatheter Mitral Valve Replacement (TMVR) Market
Due to the COVID-19 pandemic, the global Transcatheter Mitral Valve Replacement (TMVR) market size is estimated to be worth US$ 1157.5 million in 2021 and is forecast to a readjusted size of US$ 1157.5 million by 2028 with a CAGR of 27.7% during the review period. Fully considering the economic change by this health crisis, by Type accounting for % of the Transcatheter Mitral Valve Replacement (TMVR) global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR in the post-COVID-19 period. While by Type segment is altered to an % CAGR throughout this forecast period.
The classification of Transcatheter Mitral Valve Replacement (TMVR) includes MitraClip, Edwards PASCAL and Edwards SAPIEN 3. The market share of MitraClip in 2019 reached up to over 96%.
United States and Europe are the largest consumption place, with a revenue market share nearly 96% in 2019. The rest of global market mostly was taken up by China and Japan, which totally occupied a market share of over 2%.
Global Transcatheter Mitral Valve Replacement (TMVR) Scope and Market Size
The global Transcatheter Mitral Valve Replacement (TMVR) market is segmented by company, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Transcatheter Mitral Valve Replacement (TMVR) market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2017-2028.
Segment by Type
MitraClip
Edwards PASCAL
Edwards SAPIEN 3
Segment by Application
Functional Mitral Regurgitation (FMR)
Degenerative Mitral Regurgitation (DMR)
By Region
United States
Europe
China
Japan
Southeast Asia
India
Other Regions
By Company
Abbott
Edwards Lifesciences
Medtronic
Boston Scientific
Micro Interventional Devices
Neovasc
LivaNova
HighLife SAS
Market Analysis and Insights: Global Transcatheter Mitral Valve Replacement (TMVR) Market
Due to the COVID-19 pandemic, the global Transcatheter Mitral Valve Replacement (TMVR) market size is estimated to be worth US$ 1157.5 million in 2021 and is forecast to a readjusted size of US$ 1157.5 million by 2028 with a CAGR of 27.7% during the review period. Fully considering the economic change by this health crisis, by Type accounting for % of the Transcatheter Mitral Valve Replacement (TMVR) global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR in the post-COVID-19 period. While by Type segment is altered to an % CAGR throughout this forecast period.
The classification of Transcatheter Mitral Valve Replacement (TMVR) includes MitraClip, Edwards PASCAL and Edwards SAPIEN 3. The market share of MitraClip in 2019 reached up to over 96%.
United States and Europe are the largest consumption place, with a revenue market share nearly 96% in 2019. The rest of global market mostly was taken up by China and Japan, which totally occupied a market share of over 2%.
Global Transcatheter Mitral Valve Replacement (TMVR) Scope and Market Size
The global Transcatheter Mitral Valve Replacement (TMVR) market is segmented by company, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Transcatheter Mitral Valve Replacement (TMVR) market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2017-2028.
Segment by Type
MitraClip
Edwards PASCAL
Edwards SAPIEN 3
Segment by Application
Functional Mitral Regurgitation (FMR)
Degenerative Mitral Regurgitation (DMR)
By Region
United States
Europe
China
Japan
Southeast Asia
India
Other Regions
By Company
Abbott
Edwards Lifesciences
Medtronic
Boston Scientific
Micro Interventional Devices
Neovasc
LivaNova
HighLife SAS
Frequently Asked Questions
This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.
- By product type
- By End User/Applications
- By Technology
- By Region
The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.
